Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderate vs. Deep Neuromuscular Block in Vocal Cord Surgery
NCT02888067Phase 1Terminated
- Start
- Jul 2017
- Primary completion
- Jul 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sugammadex in Vocal fold lesion (VFL) (2 arms). Primary endpoint: Surgical Rating Scale. Started Jul 2017; status: terminated.
02
Drugs
Sugammadex
03
Conditions
Vocal fold lesion (VFL)
Beyond the preview
Go deeper on NCT02888067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02888067.